Omid Farhang
A product can be real, well made, and accurately labeled without being useful for the problem I want to solve.
That distinction is easy to lose. A label may emphasize a large dose, a natural source, a proprietary process, or the phrase “clinically studied.” None of those phrases alone establishes that the product improves an outcome that matters to me.
This article is the product-level part of the decision process. The first article in this series asks whether an intervention makes sense. The second asks whether the situation calls for monitoring, supportive care, medication, or medical help. Here I assume I have a reason to consider a product and work through what I need to know before using it.
This is a health-literacy method, not a recommendation to take any of the examples below. Individual needs, diagnoses, doses, contraindications, and interactions require qualified advice.
The label examples and regulatory references are from the United States because the FDA and NIH publish accessible source material. Product labels, approval systems, and available services differ by country; I would use the equivalent regulator and clinical guidance where I live.
Start with a one-sentence purpose
Before reading the front of the package, I write the proposed purpose in one sentence:
I am considering this exact product, at this dose and schedule, to improve this outcome, for this duration.
If I cannot complete that sentence, I do not yet have a decision to evaluate. “For immunity,” “for wellness,” and “because I might be deficient” are starting questions, not measurable purposes.
The sentence also prevents category drift. Evidence that iron corrects confirmed iron deficiency does not show that everyone with fatigue should take iron. Evidence for one probiotic strain and outcome does not establish that every product labeled probiotic improves general gut health.
The six checks
1. Intended use and evidence of benefit
I begin with the outcome, not the ingredient’s reputation.
Useful questions include:
- What exact condition, deficiency, symptom, or risk is this meant to address?
- Is the aim to treat a cause, reduce a symptom, prevent a complication, or correct a measured deficiency?
- Were the studies done in people like the intended user?
- Did they test the same ingredient, form, dose, route, and duration?
- Did they measure an outcome that matters, or only a laboratory marker?
- How large and reliable was the benefit?
A plausible mechanism is not the same as a demonstrated clinical benefit. “Supports” on a package can also hide the absence of a defined outcome. I look for independent clinical guidance, systematic reviews, and primary studies when the decision warrants that depth—not only material from a seller.
For a medicine, I compare the labeled indication with the symptom I am trying to relieve. A cough suppressant, expectorant, antihistamine, pain reliever, and decongestant have different purposes. A multi-symptom package is not automatically appropriate because one symptom on the box matches mine.
2. Active ingredients, serving size, dose, and formulation
I read the factual panel rather than relying on the product name.
For a supplement, the Supplement Facts panel shows the serving size, dietary ingredients, and amount per serving. The FDA explains that the serving size may be more than one tablet or capsule. “500 mg per serving” means something different when a serving is one capsule versus four.
For an over-the-counter medicine, I check the Drug Facts label for:
- each active ingredient and its amount;
- the purpose of each ingredient;
- uses;
- warnings and circumstances in which not to use it;
- directions, interval, and maximum amount;
- inactive ingredients that matter for allergies or intolerances;
- storage and expiry information.
Form matters too. Different salts, release mechanisms, routes, and preparations can change absorption, timing, tolerability, or whether evidence transfers to the product in front of me. I do not assume two products are interchangeable because the front labels use the same familiar nutrient or drug name.
3. Product quality, purity, storage, and manufacturing controls
Quality asks whether the container reliably holds what it claims, in the claimed amount, without unacceptable contamination, until the stated expiry under the stated storage conditions.
In the United States, supplement manufacturers must follow current good manufacturing practices. Those controls address identity, purity, strength, composition, and contamination. But the FDA does not approve dietary supplements for safety and effectiveness before they are sold.
That means “manufactured in a regulated facility” and “clinically effective” answer different questions.
When quality is especially important, I look for:
- a complete, legible label and identifiable manufacturer or distributor;
- lot number and expiry or use-by date;
- storage conditions I can actually maintain;
- transparent amounts rather than a blend that hides individual doses;
- credible independent certification that verifies the claim it makes;
- recalls, safety communications, or regulatory warnings.
Third-party certification can support identity, amount, and contamination claims within the certification’s scope. It does not prove that the product will produce a health benefit.
4. Safety, contraindications, and interactions
“Available without a prescription” does not mean safe for every person, combination, dose, or duration.
I check:
- allergies and previous adverse reactions;
- pregnancy or breastfeeding;
- age-related restrictions;
- kidney, liver, heart, bleeding, gastrointestinal, or other relevant conditions;
- planned surgery or procedures;
- interactions with prescriptions, over-the-counter medicines, food, alcohol, and other supplements;
- whether the product can alter a laboratory test or mask a symptom;
- signs that mean stop and seek help.
The FDA warns that supplements can change the absorption, metabolism, or excretion of medicines. The result can be too much or too little of a medicine in the body. A timing instruction can therefore be part of safety and effectiveness, not a packaging detail.
5. Duplicate ingredients and total exposure
I make one list of active ingredients across everything I take. Brand names are not enough.
Duplication can be obvious—two vitamin D supplements—or hidden inside products marketed for different purposes. A multivitamin, electrolyte powder, sleep product, antacid, and cold medicine can overlap with a separate supplement or medicine.
The total I check is:
amount per unit × units per dose × doses per day, added across all products
I then compare that total with the product directions and appropriate clinical limits. The relevant limit may count food, fortified foods, medicines, and supplements differently, so I do not apply one nutrient’s rule to another.
6. When to ask a pharmacist or clinician
I ask before using the product when the answer depends on diagnosis, test results, organ function, pregnancy, age, a chronic condition, surgery, or another medicine.
A pharmacist is particularly useful for:
- identifying the same active ingredient under different brand names;
- checking drug–drug and drug–supplement interactions;
- explaining timing, formulation, and administration;
- reviewing whether a combination product contains ingredients I do not need.
A clinician may need to determine whether the symptom or suspected deficiency has the cause I assume, whether a test is appropriate, and whether treatment changes monitoring. Bringing a complete list—with product names, active ingredients, doses, and frequency—is more useful than saying I take “some vitamins.”
Worked example: probiotics
“Probiotic” describes a broad category, not one interchangeable intervention.
For a probiotic product, I look for the genus, species, and strain; colony-forming units (CFUs) per serving; evidence for that specific strain or combination and intended outcome; expiry or use-by date; and storage instructions.
The NIH Office of Dietary Supplements explains that higher CFU counts do not necessarily mean greater benefit. Benefits, when present, depend on the microorganisms and amount. CFUs can decline over time, so a count guaranteed through the use-by date is more informative than a count at manufacture.
Storage can decide whether the viable count on the label remains plausible. Some products require refrigeration; others are stable at room temperature. A suitable strain stored incorrectly is not the same product evaluated in a study.
This example shows why category evidence is not enough. My guide to prebiotics, probiotics, and postbiotics is useful background, but it cannot choose a product without an intended use and product-specific evidence.
Worked example: magnesium
Magnesium demonstrates why the source of a number matters.
The recommended intake includes magnesium from food, beverages, supplements, and medicines. By contrast, the NIH upper limit of 350 mg per day for adults applies only to magnesium from supplements and medications, not magnesium naturally present in food.
That distinction prevents two opposite errors: treating the upper limit as a target, or wrongly counting ordinary food toward a limit defined for supplemental magnesium.
Form and interaction timing matter too. Magnesium can reduce the absorption of some antibiotics and osteoporosis medicines. A pharmacist can check the exact products and timing rather than relying on a generic rule copied from another formulation.
The lesson is not “take less magnesium.” It is: identify why it is being considered, read the elemental amount per serving, understand which sources a limit includes, and check the form and interactions.
Worked example: iron
Iron shows why “might help” can be a poor reason to self-treat.
Fatigue has many possible causes. Taking iron without establishing iron deficiency can delay a better explanation and expose someone to gastrointestinal effects or excess iron. A clinician can decide which history and tests are relevant and whether treatment needs follow-up.
The NIH notes that iron can reduce the effectiveness of levothyroxine and levodopa, and calcium may interfere with iron absorption. That turns a simple-looking mineral into a schedule and interaction question.
The label check also needs the amount of elemental iron, the serving size, the formulation, and the total from multivitamins or other products. A high-dose product is not evidence of a greater need.
Worked example: vitamin D
Vitamin D demonstrates the gap between an association, a measured deficiency, and a universal supplement claim.
Low vitamin D status can be associated with many conditions without supplementation necessarily improving those conditions. I look for evidence that the proposed dose changes the intended outcome in the relevant population, not merely that people with the condition often have lower levels.
Dose units can also obscure comparison: labels may use micrograms, international units, or both. I convert them consistently before adding totals across products.
The NIH vitamin D fact sheet also lists interactions with medicines including orlistat, some statins, steroids, and thiazide diuretics. This is another reason a nutrient label cannot be evaluated separately from a medication list.
Worked example: a combination cold medicine
A combination cold product illustrates duplication and unnecessary ingredients better than almost anything else in the medicine cabinet.
Suppose one package contains a pain reliever, cough suppressant, expectorant, and decongestant. If I have only pain and fever, the extra ingredients add warnings and possible adverse effects without a purpose. If I also take a separate pain reliever, I may duplicate the active ingredient without recognizing it from the brand names.
The FDA notes that acetaminophen—also called paracetamol and sometimes abbreviated on prescription labels—is present in hundreds of prescription and over-the-counter products. It advises not using more than one acetaminophen-containing product at a time.
My check is therefore ingredient by ingredient:
- Which symptom is each active ingredient intended to relieve?
- Do I have that symptom?
- Is the ingredient appropriate given my conditions and other medicines?
- Is it already present in another product?
- What is the total dose and interval?
Sometimes a single-ingredient product makes the decision easier to evaluate. That is not a rule that combinations are always wrong; it is a reason to require a purpose for every active ingredient.
The decision worksheet
Before using a product, I want to be able to fill in this record:
- Purpose: The exact outcome I want to change.
- Need: What establishes that this intervention is appropriate?
- Evidence: What source supports this ingredient, form, dose, duration, and population?
- Product: Active ingredients, amount per serving, formulation, and inactive ingredients that matter.
- Schedule: Dose, interval, duration, and timing relative to food, medicines, or supplements.
- Quality: Manufacturer, lot, expiry, storage, and relevant independent verification.
- Safety: Contraindications, adverse effects, interactions, and stop conditions.
- Duplicates: Total exposure across every medicine and supplement.
- Reassessment: How I will know whether it helped, failed, or caused harm.
- Advice: What a pharmacist or clinician needs to confirm.
An unanswered item is not always a reason to reject a product. It is a reason to recognize what I do not yet know and whether that uncertainty matters enough to pause.
What this method changes
The method replaces “Is this product good?” with narrower questions:
- Good for which outcome?
- Supported by what evidence?
- At which dose, in which form, for whom, and for how long?
- Manufactured and stored well enough to match the label?
- Safe alongside everything else?
- Worth using compared with monitoring, another intervention, or no product?
That last comparison reconnects product literacy to the rest of the series. A perfectly evaluated medicine can still be unnecessary. A supplement with convincing quality documentation can still lack evidence for the intended outcome. And a useful intervention can still be wrong for a particular person because of dose, timing, contraindications, or interactions.
Understanding the product matters only after understanding the problem. The label is evidence about what is in the container—not proof that I should take it.